×
About 1,263 results

ALLMedicine™ Anticoagulation Center

Research & Reviews  454 results

Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art...
https://doi.org/10.1016/j.jacc.2021.10.037
Journal of the American College of Cardiology; Volgman AS, Nair G et. al.

Jan 15th, 2022 - The prevalence of atrial fibrillation (AF) is increasing as the population ages. AF treatment-related complications also increase markedly in older adults (defined as ≥75 years of age for this review). The older AF population has a high risk of st...

Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A sys...
https://doi.org/10.1016/j.pan.2021.12.008
Pancreatology : Official Journal of the International Ass... Sissingh NJ, Groen JV et. al.

Jan 12th, 2022 - The optimal management of patients with acute pancreatitis (AP) and splanchnic vein thrombosis (SVT) remains unknown. This systematic review and meta-analysis aimed to see if therapeutic anticoagulation (AC) improves outcomes in patients with AP a...

Does Pre-existing Anticoagulation or Antiplatelet Therapy Increase the Risk of Traumati...
https://doi.org/10.1227/NEU.0000000000001791
Neurosurgery Harland TA, Prabhala T et. al.

Jan 11th, 2022 - Isolated traumatic subarachnoid hemorrhage (tSAH) is a common finding in mild traumatic brain injury that often results in transfer to a tertiary center. Patients prescribed blood-thinning medications (BTs) are believed to be at higher risk of cli...

Incidence, persistence, and clinical relevance of iatrogenic atrial septal defects afte...
https://doi.org/10.1111/echo.15271
Echocardiography (Mount Kisco, N.Y.); Nelles D, Vij V et. al.

Dec 19th, 2021 - To investigate the rate and clinical impact of a persisting iatrogenic atrial septal defect (iASD) after percutaneous left atrial appendage occlusion (LAAO). Percutaneous LAAO is an alternative to oral anticoagulation (OAC) for the prevention of i...

Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial ...
https://doi.org/10.1093/eurheartj/ehab847
European Heart Journal; Labori F, Persson J et. al.

Dec 18th, 2021 - This study aims to estimate the cost-effectiveness of percutaneous left atrial appendage occlusion (LAAO) compared to standard stroke prevention care for patients with atrial fibrillation (AF) and contraindication to oral anticoagulation (OAC) in ...

see more →

Drugs  1 results see all →

News  50 results

Half-Dose DOACs Cut Bleeding, Thrombus Risk Post-Watchman LAA Closure
https://www.medscape.com/viewarticle/960974

Oct 15th, 2021 - In a potential case of "less is more," an antithrombotic regimen with only short-term antiplatelets and long-term reliance on direct oral anticoagulants (DOACs) — but at half the standard dosages — led to an almost 90% drop in risk of thromboembol...

AF a Stroke Cause or Innocent Bystander? The Debate Continues
https://www.medscape.com/viewarticle/960224

Oct 4th, 2021 - Discovery of substantial atrial fibrillation (AF) is usually an indication to start oral anticoagulation (OAC) for stroke prevention, but it's far from settled whether such AF is actually a direct cause of thromboembolic stroke. And that has impli...

Amulet Bests Watchman for LAAO But Not for Bleeding: AMULET-IDE
https://www.medscape.com/viewarticle/957571

Aug 30th, 2021 - Abbott's Amplatzer Amulet provided superior left atrial appendage (LAA) closure over the old-guard Watchman (Boston Scientific) device but failed to significantly cut stroke or bleeding rates in patients with atrial fibrillation, despite theoretic...

LOOP Trial Undercuts Value of Long-term Continuous ECG Screening for Atrial Fibrillation
https://www.medscape.com/viewarticle/957473

Aug 29th, 2021 - UPDATED AUGUST 30, 2021 // Maybe short, asymptomatic bouts of atrial fibrillation (AF) that show up on long-term, continuous monitoring aren't worth hunting for just so oral anticoagulation (OAC) can be started, even in elderly people with other s...

Are Left Atrial Thrombi That Defy Preprocedure Anticoagulation Predictable?
https://www.medscape.com/viewarticle/952793

Jun 9th, 2021 - Three or more weeks of oral anticoagulation (OAC) sometimes isn't up to the job of clearing any potentially embolic left atrial (LA) thrombi before procedures like cardioversion or catheter ablation in patients with atrial fibrillation (AF). Such ...

see more →